
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Division of Hematooncology, Department of Pediatrics, 2 Department of Pathology, 3 Division of Neurosurgery, Montreal Children's Hospital and 4 Division of Neurosurgery, Montreal Neurological Institute, Brain Tumour Research Centre, McGill University Health Center; 5 Biotechnology Research Institute, National Research Council of Canada, Montreal, Canada; 6 Oncology Department, Pediatrics Hospital, Centro Medico Nacional Siglo XXI, Mexico City, Mexico; 7 2nd Department of Pediatrics, Faculty of Medicine, Semmelweis University; 8 Division of Neurosurgery, Division of Pathology, National Institute of Neurosurgery, Budapest, Hungary; and 9 Department of Neurosurgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary
Requests for reprints: Nada Jabado, Montreal Children's Hospital Research Institute, 4060 Saint Catherine West, PT-239, Montreal, Quebec, Canada, H3Z 2Z3. Phone: 514-412-4400, ext. 23270; Fax: 514-412 4331; E-mail: nada.jabado{at}mcgill.ca.
Purpose: Gene expression profiling has proved crucial for understanding the biology of cancer. In rare diseases, including pediatric glioblastoma (pGBM), the lack of readily available fresh frozen (FF) material limits the feasibility of this analysis, as well as its validation, on independent data sets, a step needed to ensure relevance, mandating the use of alternate RNA sources. To overcome the limitation of material number and to validate results we obtained on FF pGBM, we did microarray analysis on RNA extracted from formalin-fixed, paraffin-embedded archival samples from pGBM and control brains, wherein we had no control on the fixation process.
Experimental Design: RNA from 16 pGBM and 3 control brains was extracted and linearly amplified. Reverse transcription–PCR on housekeeping and formerly identified tumor-associated genes and microarray analysis were done on this RNA source. Results were validated by immunohistochemistry.
Results: Despite extensive RNA degradation, microarray analysis was possible on 16 of 19 samples and reproduced the pattern of results obtained on FF pGBM. Gene lists and ontology subgrouping were highly concordant in both sample types. Similar to the findings on FF samples, we were able to identify two subsets of pGBM based on their association/lack of association with evidence consistent with an active Ras pathway.
Conclusions: Archival formalin-fixed, paraffin-embedded tissues are an invaluable resource as they are the most widely available materials often accessible in conjunction with clinical and follow-up data. Gene expression profiling on this material is feasible and may represent a significant advance for understanding the biology of rare human diseases.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |